Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin Tablets, 20 mg, for the Management of Essential Hypertension

NCT03514641 is registered in ClinicalTrials.gov with Theracos as lead sponsor.

NCT NCT03514641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03514641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin Tablets, 20 mg, for the Management of Essential Hypertension
Lead sponsor
Theracos
Phase
Phase 2/3
Overall status
Completed
Start date
October 18, 2017
Completion date
November 30, 2018
Enrollment
673 (actual)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension